TMEM41B

Transmembrane protein 41B · Q5BJD5 · TMEM41B on Sugi Atlas →

0 patent compounds predicted against TMEM41B, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TMEM41B by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy PHASE2RECRUITING
Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers PHASE2COMPLETED
Treatment of Ectopic Calcification in Fahr's Disease or Syndrome PHASE2RECRUITING
Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL) PHASE1COMPLETED
PBA Use for Treatment of ATF6-/- Patients EARLY_PHASE1SUSPENDED
Role of TMEM219 Marker in Type 1 Diabetes nanUNKNOWN
Organoid Study R334W nanWITHDRAWN
Evaluation of Serum Tumor Endothelial Marker1 as a Potential Biomarker for Colorectal Cancer Diagnosis and Cancer Progression nanNOT_YET_RECRUITING
Energy Balance and Weight Gain With Ivacaftor Treatment nanCOMPLETED
Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias nanCOMPLETED
Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis nanCOMPLETED
Bone Microarchitecture at the Radius: a Pilot Comparison Between Children With Cystic Fibrosis and Healthy Controls nanCOMPLETED
Genetic Study of Age-Related Macular Degeneration nanCOMPLETED
Clinical and Genetic Profile of Pediatric Patients With Cystic Fibrosis in Sohag. nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
New Markers of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Function in Sweat nanUNKNOWN
Seven Year Update of Macular Degeneration Patients nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Markers and Mechanisms of Macrovascular Disease in IDDM nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Surfactant Derived Protocol in Heart Failure nanCOMPLETED
Fatty Acid Metabolism and Insulin Sensitivity: the Role of Endurance Exercise nanCOMPLETED
Stem Cell Models of Best Disease and Other Retinal Degenerative Diseases. nanCOMPLETED
Effect of SLC01B1 (rs4149956) Polymorphism on the Efficacy and Tolerability of Atorvastatin in Pakistani Population nanCOMPLETED
Brain P-gp and Inflammation in People With Epilepsy nanCOMPLETED
A Prospective Study of Advanced Diagnostics in People With an Unclear Diagnosis of Cystic Fibrosis nanNOT_YET_RECRUITING
Immunological Profile and Clinical Characteristics of Children Diagnosed With Chronic Granulomatous Disease nanUNKNOWN
Renal Transporters After Renal Transplantation nanUNKNOWN
Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists. nanRECRUITING
Detection of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity in Rectal Tissues From Human Subjects nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a TMEM41B binder may also engage these)

ProteinNameSimilarity
Q8K1A5 1.000 Q8K1A5 →
Q5FVN2 1.000 Q5FVN2 →
Q5RBZ8 1.000 Q5RBZ8 →
Q5U4K5 1.000 Q5U4K5 →
A1A5V7 0.998 A1A5V7 →
A4II98 0.997 A4II98 →
Q5ZIL6 0.997 Q5ZIL6 →
Q9VX39 0.988 Q9VX39 →
O62126 0.986 O62126 →
Q6NV38 0.980 Q6NV38 →
Q8L586 0.979 Q8L586 →
Q759P7 0.976 Q759P7 →
Q7Z3F1 0.976 Q7Z3F1 →
Q0DWA9 0.975 Q0DWA9 →
P53793 0.975 P53793 →
Q5R9A7 0.975 Q5R9A7 →
Q6IWY1 0.974 Q6IWY1 →
A8I499 0.974 A8I499 →
Q5Z413 0.973 Q5Z413 →
Q28E01 0.973 Q28E01 →
Q8W469 0.973 Q8W469 →
Q9JJL3 0.973 Q9JJL3 →
Q94BZ1 0.973 Q94BZ1 →
F1Q8R9 0.972 F1Q8R9 →
Q9UIG8 0.972 Q9UIG8 →
A0JNI9 0.972 A0JNI9 →
Q99J94 0.972 Q99J94 →
Q9LRP2 0.972 Q9LRP2 →
O64759 0.972 O64759 →
Q9QZX8 0.972 Q9QZX8 →